do we need to adjust total dose according to the new NIST calibration measurement?
PURPOSE: To detect the need of adjusting the apical total dose according to the new NIST calibration measurement introduced by BEBIG Isotopen und Medizintechnik GmbH for the treatment of choroidal melanoma. As the total radiation dose should not be individualized depending on errors pf previous calibration but can be applicable if based on a radiosensitivity test that was able to predict the final response of tumor to radiation for each particular patient. PATIENTS AND METHODS: Twenty patients with choroidal melanomas were treated between November 2002 and July 2004 at “Suzanne Mubarak Eye Tumor Centre”, National Eye centre Rod-EL Farag, Cairo, Egypt. The prescribed dose was calculated according to the new NISTcalibrated dosimetry introduced by BEBIG, but without dose modification by using a conversion factor F(type,z) from the ASMW calibrated measurement to the NIST calibrated measurement that have been calculated depending on the plaque type and the distance z from the inner concave
Related Questions
- Why use Finapres or Portapres rather than intra-arterial or intermittent non-invasive techniques of blood pressure measurement?
- Computed tomography dose and variability of airway dimension measurements: how low can we go?
- do we need to adjust total dose according to the new NIST calibration measurement?
